USE OF GTF21 MUTATIONS IN THE PROGNOSIS OF THYMIC CANCERS

• 收藏
• 分享

专利权人:

发明人:

Giuseppe Giaccone,Yisong Wang,Iacopo Petrini

申请号：

US14676987

公开号：

US20150284807A1

申请日:

2015.04.02

申请国别(地区):

US

年份:

2015

代理人:

摘要：

Disclosed are methods of determining the prognosis of thymic cancer in a subject comprising detecting a mutation in the general transcription factor IIi (GTF2I) genetic sequence or protein. The presence of a GTF2I mutation indicates that the thymic cancer is indolent.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/